A detailed history of Redwood Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Redwood Investment Management, LLC holds 151,450 shares of BMY stock, worth $8.06 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
151,450
Previous 144,112 5.09%
Holding current value
$8.06 Million
Previous $7.82 Million 13.67%
% of portfolio
0.58%
Previous 0.74%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $295,354 - $388,840
7,338 Added 5.09%
151,450 $6.75 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $410,420 - $465,337
8,554 Added 6.31%
144,112 $7.82 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $6.15 Million - $7.34 Million
126,893 Added 1464.43%
135,558 $6.96 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $501,616 - $560,885
8,665 New
8,665 $503,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $1.58 Million - $1.79 Million
24,074 New
24,074 $1.67 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $1.16 Million - $1.28 Million
16,005 New
16,005 $1.23 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $1.8 Million - $2.16 Million
-29,344 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $1.57 Million - $1.83 Million
29,344 New
29,344 $1.83 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $321,320 - $466,952
-6,925 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $22,587 - $29,463
459 Added 7.1%
6,925 $445,000
Q3 2019

Nov 18, 2019

BUY
$42.77 - $50.71 $276,550 - $327,890
6,466 New
6,466 $328,000
Q2 2019

Aug 15, 2019

SELL
$44.62 - $49.34 $301,095 - $332,946
-6,748 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$44.62 - $49.34 $301,095 - $332,946
6,748 New
6,748 $306,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Redwood Investment Management, LLC Portfolio

Follow Redwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investment Management, LLC with notifications on news.